Digital Psychosocial Interventions on Stigma and Health Outcomes in TB Patients
ConditionTuberculosis (TB)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPeking Union Medical College
About this trial
This study addresses the shortcomings of routine clinical management for tuberculosis (TB) patients by proposing psychosocial interventions targeting stigma, while investigating the current status of stigma, psychological issues, medication adherence, and drug resistance among tuberculosis patients. It analyzes the underlying mechanisms, integrates online mindfulness courses, digital cognitive behavioral therapy (CBT), and human-machine interactive dialogue modules to develop a digital psychosocial intervention platform. Through a randomized controlled trial, the study validates the impact of the platform on stigma and health outcomes among tuberculosis patients in China. Ultimately, the research aims to formulate a scalable digital psychosocial intervention technical solution, providing evidence-based support for optimizing China's comprehensive tuberculosis prevention and control model.
Eligibility criteria
Qualifiers
Patients diagnosed with active pulmonary tuberculosis within the past 1 year via bacteriological tests (smear microscopy or culture) and/or molecular biological assays (e.g., GeneXpert).
Capable of independently completing questionnaires and scale assessments; accessible for sputum collection, chest radiography, biomarker testing and other examinations.
Provided full informed consent for the entire study and signed the written informed consent form.
Disqualifiers
Presence of severe chronic diseases such as immune system disorders, or severe neurological and psychiatric disorders.
No access to electronic devices required for subsequent online intervention.
Cognitive impairment or hearing loss that impairs normal communication and prevents cooperation with surveys and intervention procedures.
Concurrent participation in other health promotion or clinical intervention studies.
Trial design
Treatments tested in this trial
- Online Mindfulness
- Online CBT Intervention
- Human-computer Interaction
- Routine treatment and management services provided by the tuberculosis prevention and control system
Treatment groups
496 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Peking Union Medical College
Lead sponsor
Beijing Center for Disease Prevention and Control
Collaborator
Hainan Provincial Center for Disease Control and Prevention
Collaborator
Yichang Center for Disease Control and Prevention, China
Collaborator
Source ClinicalTrials.gov